{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:35:37Z","timestamp":1791905737377,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1124\/jpet.105.090944","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T19:49:17Z","timestamp":1132170557000},"page":"1298-1305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention"],"prefix":"10.1016","volume":"315","author":[{"given":"Ning","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui-Po","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha L.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.090944_bib1","doi-asserted-by":"crossref","unstructured":"Botting RM (2000) Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31: S202\u2013S210.","DOI":"10.1086\/317520"},{"key":"10.1124\/jpet.105.090944_bib2","doi-asserted-by":"crossref","unstructured":"Chandrasekharan NV, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, and Simmons DL (2002) From the cover: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA 99: 13926\u201313931.","DOI":"10.1073\/pnas.162468699"},{"key":"10.1124\/jpet.105.090944_bib3","doi-asserted-by":"crossref","unstructured":"DeWitt D and Smith W (1988) Primary structure of prostaglandin G\/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 85: 1412\u20131416.","DOI":"10.1073\/pnas.85.5.1412"},{"key":"10.1124\/jpet.105.090944_bib4","doi-asserted-by":"crossref","unstructured":"Dinchuk JE, Liu RQ, and Trzaskos JM (2003) COX-3: in the wrong frame in mind. Immunol Lett 86: 121.","DOI":"10.1016\/S0165-2478(02)00268-7"},{"key":"10.1124\/jpet.105.090944_bib5","doi-asserted-by":"crossref","unstructured":"Gott JM (2003) Expanding genome capacity via RNA editing. C R Biol 326: 901\u2013908.","DOI":"10.1016\/j.crvi.2003.09.004"},{"key":"10.1124\/jpet.105.090944_bib6","doi-asserted-by":"crossref","unstructured":"Hla T (1996) Molecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcript. Prostaglandins 51: 81\u201385.","DOI":"10.1016\/0090-6980(95)00158-1"},{"key":"10.1124\/jpet.105.090944_bib7","doi-asserted-by":"crossref","unstructured":"Hla T and Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89: 7384\u20137388.","DOI":"10.1073\/pnas.89.16.7384"},{"key":"10.1124\/jpet.105.090944_bib8","doi-asserted-by":"crossref","unstructured":"Kis B, Snipes A, Bari F, and Busija DW (2004) Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system. Mol Brain Res 126: 78\u201380.","DOI":"10.1016\/j.molbrainres.2004.03.015"},{"key":"10.1124\/jpet.105.090944_bib9","doi-asserted-by":"crossref","unstructured":"Kis B, Snipes JA, Isse T, Nagy K, and Busija DW (2003) Putative cyclooxygenase-3 expression in rat brain cells. J Cereb Blood Flow Metab 23: 1287\u20131292.","DOI":"10.1097\/01.WCB.0000090681.07515.81"},{"key":"10.1124\/jpet.105.090944_bib10","doi-asserted-by":"crossref","unstructured":"Merlie J, Fagan D, Mudd J, and Needleman P (1988) Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 263: 3550\u20133553.","DOI":"10.1016\/S0021-9258(18)68959-8"},{"key":"10.1124\/jpet.105.090944_bib11","doi-asserted-by":"crossref","unstructured":"O\u2019Banion M, Winn V, and Young D (1992) cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89: 4888\u20134892.","DOI":"10.1073\/pnas.89.11.4888"},{"key":"10.1124\/jpet.105.090944_bib12","doi-asserted-by":"crossref","unstructured":"Oshima M and Taketo MM (2002) COX selectivity and animal models for colon cancer. Curr Pharm Des 8: 1021\u20131034.","DOI":"10.2174\/1381612023394953"},{"key":"10.1124\/jpet.105.090944_bib13","doi-asserted-by":"crossref","unstructured":"Otto J, DeWitt D, and Smith W (1993) N-Glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem 268: 18234\u201318242.","DOI":"10.1016\/S0021-9258(17)46835-9"},{"key":"10.1124\/jpet.105.090944_bib14","doi-asserted-by":"crossref","unstructured":"Schwab JM, Beiter T, Linder JU, Laufer S, Schulz JE, Meryermann R, and Schluesener HJ (2003) COX-3\u2013a virtual pain target in humans? FASEB J 17: 2174\u20132175.","DOI":"10.1096\/fj.03-0595lte"},{"key":"10.1124\/jpet.105.090944_bib15","doi-asserted-by":"crossref","unstructured":"Shaftel SS, Olschowka JA, Hurley SD, Moore AH, and O\u2019Banion MK (2003) COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Mol Brain Res 119: 213\u2013215.","DOI":"10.1016\/j.molbrainres.2003.09.006"},{"key":"10.1124\/jpet.105.090944_bib16","doi-asserted-by":"crossref","unstructured":"Snipes JA, Kis B, Shelness GS, Hewett JA, and Busija DW (2005) Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat. J Pharmacol Exp Ther 313: 668\u2013676.","DOI":"10.1124\/jpet.104.079533"},{"key":"10.1124\/jpet.105.090944_bib17","doi-asserted-by":"crossref","unstructured":"Spencer AG, Thuresson E, Otto JC, Song I, Smith T, DeWitt DL, Garavito RM, and Smith WL (1999) The membrane binding domains of prostaglandin endoperoxide H synthases 1 and 2. Peptide mapping and mutational analysis. J Biol Chem 274: 32936\u201332942.","DOI":"10.1074\/jbc.274.46.32936"},{"key":"10.1124\/jpet.105.090944_bib18","doi-asserted-by":"crossref","unstructured":"Ulrich CM, Bigler J, Sibert J, Greene EA, Sparks R, Carlson CS, and Potter JD (2002) Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Hum Mutat 20: 409\u2013410.","DOI":"10.1002\/humu.9080"},{"key":"10.1124\/jpet.105.090944_bib19","doi-asserted-by":"crossref","unstructured":"Vane J (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232\u2013235.","DOI":"10.1038\/newbio231232a0"},{"key":"10.1124\/jpet.105.090944_bib20","doi-asserted-by":"crossref","unstructured":"Wang LH, Hajibeigi A, Xu XM, Loose-Mitchell D, and Wu KK (1993) Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem Biophys Res Commun 190: 406\u2013411.","DOI":"10.1006\/bbrc.1993.1062"},{"key":"10.1124\/jpet.105.090944_bib21","doi-asserted-by":"crossref","unstructured":"Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, and De Marzo AM (2004) Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215: 1\u201320.","DOI":"10.1016\/j.canlet.2004.06.014"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524323754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524323754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.090944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:41:21Z","timestamp":1740001281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524323754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022356524323754"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.090944","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.090944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}